MedTrace Logo

The Efficacy of Adductor-Canal-Block (ACB) in Patients After Knee Arthroscopy

NCT01254825 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2012-09-11

No results posted yet for this study

Summary

The Purpose of this study is to determine whether Adductor-Canal-Block (ACB) is superior to placebo when it comes to analgetic efficacy after Knee-Arthroscopy.

Conditions

  • Meniscus Lesion
  • Pain (Knee)
  • Diagnostic Knee Artroscopy
  • Minor Knee Surgery

Interventions

PROCEDURE

Adductor-Canal-Block, Ropivacain

Ultrasound-guided ACB; 30 mL Ropivacain 7,5 mg/mL. Single dose.

PROCEDURE

Adductor Canal Block, Placebo (saline)

Ultrasound-guided Adductor Canal Block; 30 mL Saline. Single dose.

Sponsors & Collaborators

  • Glostrup University Hospital, Copenhagen

    lead OTHER

Principal Investigators

  • Malene Espelund, MD · Glostrup University Hospital, Copenhagen, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01254825 on ClinicalTrials.gov